Early research (Phase 1)Ended earlyNCT01876641
What this trial is testing
Treatment of a Resistant Disease Using Decitabine Combined With Vemurafenib Plus Cobimetinib
Who this might be right for
Metastatic MelanomaMelanomaBRAF-mutated Metastatic Melanoma+1 more
Mohammed M Milhem 18